These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Lymphocyte stimulation in patients with lymphoma cutis. Mekori T; Robinson E; Haim S Oncology; 1974; 30(4):273-7. PubMed ID: 4459741 [TBL] [Abstract][Full Text] [Related]
63. Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies. II. Chromosomal and immunologic abnormalities. Law IP; Hollinshead AC; Whang-Peng J; Dean JH; Oldham RK; Herberman RB; Rhode MC Cancer; 1977 Mar; 39(3):1229-36. PubMed ID: 303145 [TBL] [Abstract][Full Text] [Related]
64. Serial immune function testing to predict clinical disease relapse in patients with solid tumors. Braun DP; Harris JE Cancer Immunol Immunother; 1983; 15(3):165-71. PubMed ID: 6352007 [No Abstract] [Full Text] [Related]
66. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas. Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739 [TBL] [Abstract][Full Text] [Related]
67. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma. ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357 [TBL] [Abstract][Full Text] [Related]
68. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status). Libánský J; Lukásová M; Pinosová I Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205 [No Abstract] [Full Text] [Related]
69. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases. Lee YT Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179 [TBL] [Abstract][Full Text] [Related]
70. Cell-mediated immune status in patients of non-Hodgkin's lymphoma (NHL): an evaluation by skin tests, blastogenic transformation of lymphocytes and T-cell count. Misra NC; Singh VP; Saxena KC; Saxena RP; Agarwal CG Cell Mol Biol Incl Cyto Enzymol; 1979; 25(3):185-9. PubMed ID: 317434 [No Abstract] [Full Text] [Related]
71. Characterization of the blast cell in childhood non-Hodgkin's lymphoproliferative malignancies. Coccia PF Semin Oncol; 1977 Sep; 4(3):287-96. PubMed ID: 335518 [No Abstract] [Full Text] [Related]
72. Reduced natural killer cell activity in non-hodgkin's lymphoma. Neri A; Brugiatelli M; Ozger Topuz U; Astaldi G Boll Ist Sieroter Milan; 1981 Nov; 60(5):394-407. PubMed ID: 7041921 [TBL] [Abstract][Full Text] [Related]